title: Nasal delivery progesterone powder formulations comparison with oral administration.
authors.affiliation: Pharmaceutical Department, Parma, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Provasi
authors.forename: A
authors.initials: A
authors.lastname: De Ascentiis
authors.forename: A
authors.initials: A
authors.lastname: Minutello
authors.forename: P
authors.initials: P
authors.lastname: Colombo
authors.forename: P L
authors.initials: PL
authors.lastname: Catellani
mesh_terms: D000281:Administration, Intranasal; D000284:Administration, Oral; D000818:Animals; D003505:Cyclodextrins; D008297:Male; D011208:Powders; D011374:Progesterone / Q000008:administration & dosage* / Q000493:pharmacokinetics; D011817:Rabbits; D047392:beta-Cyclodextrins
chemical_list: D003505:Cyclodextrins; D011208:Powders; D047392:beta-Cyclodextrins; D011374:Progesterone; C031215:betadex